Chinese FDA gives DSM the go ahead on organic bioactives line

By Michelle Yeomans contact

- Last updated on GMT

Chinese FDA gives DSM the go ahead on organic bioactives line
DSM’s Alpaflor personal care portfolio is now fully listed by the Chinese Food & Drug Administration.

The portfolio, which has become a globally accepted standard for organic, Ecocert, Cosmos and Natrue certifications; includes organic bioactives which are produced at DSM’s manufacturing site in the Swiss Valais.

According to DSM, along with these certifications, the new listing in China will help Alpaflor to reach a wider platform around the globe.

The company has been cultivating plants and flowers at high altitude in the Swiss Alps to the standards of Bio Suisse for more than a decade. 

Last year, DSM presented in vitro and in vivo findings on Alpaflor Edelweiss, which showed 3 out of 4 consumers with sensitive skin to have a more comfortable skin feel after only 1 month of using the cream containing 3% of the substance.

Related topics: Business & Financial

Related news

Follow us

Products

View more

Webinars

Indie Pioneers Podcast

Indie Pioneers Podcast